Vimarsana
Biggest News Aggregation in the World

Anat Arbel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anat Arbel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anat Arbel Today - Breaking & Trending Today

mRNA Vaccine Cuts COVID-Related Guillain-Barré Risk - Vimarsana News

mRNA Vaccine Cuts COVID-Related Guillain-Barré Risk

COVID-19 increases the risk for Guillain-Barré syndrome sixfold, while getting the Pfizer mRNA vaccine lowers risk.

Positive Link Identified Between SARS-CoV-2 and Guillain-Barré - Vimarsana News

Positive Link Identified Between SARS-CoV-2 and Guillain-Barré

Odds ratio of 6.30 for Guillain-Barré syndrome association with SARS-CoV-2 infection and 0.41 for COVID-19 vaccine administration.

Source: empr.com
Covid: Research finds risk of developing 'extremely rare' Guillain-Barre syndrome increases due to Covid - Vimarsana News

Covid: Research finds risk of developing 'extremely rare' Guillain-Barre syndrome increases due to Covid

New research from medical institutes in Israel has found that individuals who have been infected with Covid-19 are at an increased risk of developing Guillain-Barre syndrome in the six weeks following the infection.

Getting COVID Raises Odds for Guillain-Barre Syndrome, Vaccination Lowers Risk - Vimarsana News

Getting COVID Raises Odds for Guillain-Barre Syndrome, Vaccination Lowers Risk

COVID infection can raise the risk of a rare immune system attack on the body's nerves -- but vaccination might protect against it, a large new study suggests.

Risk of Guillain-Barré syndrome 6 times higher after Covid-19 - Vimarsana News

Risk of Guillain-Barré syndrome 6 times higher after Covid-19

Washington, Oct 18 (Prensa Latina) A new study from Israel ties Covid-19 infection to an increased risk of a diagnosis of Guillain-Barre syndrome (GBS) within 6 weeks, while mRNA vaccination was linked to a decreased risk of the rare but serious autoimmune disease.